Rare
lephants
Screener
Toggle theme
Relmada Therapeutics, Inc.
RLMD
·
Healthcare, Drug Manufacturers - General, United States
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
EPS
Sales Per Share
Book Per Share
FCF Per Share
Dividend Per Share
Shares Outstanding
Share-Based Metrics
›
EPS
Compare
←
5Y
10Y
MAX
→
EPS
Chart
Table
EPS
Cyclically Adjusted EPS
Fiscal Year
EPS
Cyclically Adjusted EPS
FY2024
$-2.65
$-3.39
FY2025
$-1.45
$-3.26
Download CSV
